Divi's Laboratories Limited — Others, 14-07-2025: Shareholders meeting

Divi's Laboratories will hold its 35th Annual General Meeting via video conferencing. Key agenda items include adopting the audited financial statements for the fiscal year ended March 31, 2025, and approving a proposed dividend of ₹30 per equity share. Shareholders will also vote on re-appointing two directors, Ms. Nilima Prasad Divi and Dr. S. Devendra Rao. Additionally, the company seeks approval for the appointment of new secretarial auditors at a fee of ₹0.05 Cr for the first year. A significant proposal is the increase in monthly remuneration for Mr. Nimmagadda Venkata Anirudh, Head of Nutraceuticals and a related party, from ₹2.17 Lakh to ₹4 Lakh, recognizing his role in enhancing sales and operational efficiency in a key growth segment.